| 國立臺灣大學 |
2006 |
Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome
|
Fang, Chi?Tai; Shau, Wen-Yi; Hsueh, Po-Ren; Chen, Yee-Chun; Wang, Jann-Tay; Hung, Chien-Ching; Huang, Loreen Y. L.; Chang, Shan-Chwen |
| 臺大學術典藏 |
2018-09-10T05:44:18Z |
Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: Impact on the outcome
|
Fang, C.-T. and Shau, W.-Y. and Hsueh, P.-R. and Chen, Y.-C. and Wang, J.-T. and Hung, C.-C. and Huang, L.Y.L. and Chang, S.-C.; PO-REN HSUEH; CHI-TAI FANG; SHAN-CHWEN CHANG; YEE-CHUN CHEN; JANN-TAY WANG; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2006 |
Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: Impact on the outcome
|
Chang S.-C.; Huang L.Y.L.; Wang J.-T.; Hung C.-C.; Chen Y.-C.; PO-REN HSUEH; Chang S.-C.;Huang L.Y.L.;Hung C.-C.;Wang J.-T.;Chen Y.-C.;PO-REN HSUEH;Shau W.-Y.;Fang C.-T.; Fang C.-T.; Shau W.-Y. |
| 臺大學術典藏 |
2006 |
Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: Impact on the outcome
|
Fang C.-T.;Shau W.-Y.;Hsueh P.-R.;Yee-Chun Chen;Wang J.-T.;Hung C.-C.;Huang L.Y.L.;Chang S.-C.; Fang C.-T.; Shau W.-Y.; Hsueh P.-R.; YEE-CHUN CHEN; Wang J.-T.; Hung C.-C.; Huang L.Y.L.; Chang S.-C. |
| 臺大學術典藏 |
2021-04-20T03:46:22Z |
Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: Impact on the outcome
|
Chi-Tai Fang;Shau W.-Y.;Hsueh P.-R.;Chen Y.-C.;Wang J.-T.;Hung C.-C.;Huang L.Y.L.;Chang S.-C.; CHI-TAI FANG; Shau W.-Y.; Hsueh P.-R.; Chen Y.-C.; Wang J.-T.; Hung C.-C.; Huang L.Y.L.; Chang S.-C. |
| 臺大學術典藏 |
2021-05-06T01:52:46Z |
Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: Impact on the outcome
|
Fang C.-T.; Shau W.-Y.; Hsueh P.-R.; YEE-CHUN CHEN; Wang J.-T.; Hung C.-C.; Huang L.Y.L.; Chang S.-C. |
| 臺大學術典藏 |
2006 |
Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: Impact on the outcome
|
Chang S.-C.; Huang L.Y.L.; Hung C.-C.; JANN-TAY WANG; Chen Y.-C.; Fang C.-T.;Shau W.-Y.;Hsueh P.-R.;Chen Y.-C.;Jann-Tay Wang;Hung C.-C.;Huang L.Y.L.;Chang S.-C.; Fang C.-T.; Shau W.-Y.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-12-01T02:30:14Z |
Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: Impact on the outcome
|
Fang C.-T.; Shau W.-Y.; Hsueh P.-R.; Chen Y.-C.; Wang J.-T.; CHIEN-CHING HUNG; Huang L.Y.L.; Chang S.-C. |
| 臺大學術典藏 |
2006 |
Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: Impact on the outcome
|
Fang C.-T.;Shau W.-Y.;Hsueh P.-R.;Chen Y.-C.;Wang J.-T.;Hung C.-C.;Huang L.Y.L.;Shan-Chwen Chang; Fang C.-T.; Shau W.-Y.; Hsueh P.-R.; Chen Y.-C.; Wang J.-T.; Hung C.-C.; Huang L.Y.L.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2022-05-13T08:05:10Z |
Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: Impact on the outcome
|
Fang C.-T.; Shau W.-Y.; Hsueh P.-R.; Chen Y.-C.; JANN-TAY WANG; Hung C.-C.; Huang L.Y.L.; Chang S.-C. |
